Nursing home residents and staff were disproportionately affected by the COVID-19
pandemic, drawing attention to long-standing challenges of poor infection control …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID-
19) has spread pandemically with high rates of morbidity and mortality. COVID-19 has also …

Importance During the COVID-19 pandemic, stabilized COVID-19–positive patients were
discharged to skilled nursing facilities (SNFs) to alleviate hospital crowding. These …

Introduction Limited data exist regarding real-world utilization of nirmatrelvir/ritonavir. We
identified predictors of nirmatrelvir/ritonavir use among Veterans Affairs (VA) outpatients …

To the Editor The Agency for Healthcare Research and Quality describes the USPSTF as
follows:“The USPSTF works to improve the health of people nationwide by making …

Antiviral therapeutics for COVID-19 in nonhospitalized patients prevent progression to
severe illness, hospitalization, and death. Despite their proven benefit, utilization of these …

Importance Nursing home residents continue to bear a disproportionate share of COVID-19
morbidity and mortality, accounting for 9% of all US COVID-19 deaths in 2023, despite …

Background Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus
disease 2019 (COVID-19) but remains underutilized. Information on which eligible groups …

Introduction Oral antiviral medications are important tools for preventing severe COVID-19
outcomes. However, their uptake remains low for reasons that are not entirely understood …

Regarding monoclonal antibody treatment, there were issues with staffing competency in
placing a peripheral intravenous line, infusions that required an extended monitoring period …